US 11007265
Vaccines having an antigen and interleukin-21 as an adjuvant
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 11007265 (Vaccines having an antigen and interleukin-21 as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K39/08, A61K39/12